Edition:
United States

Kalvista Pharmaceuticals Inc (KALV.OQ)

KALV.OQ on NASDAQ Stock Exchange Global Market

23.59USD
3:59pm EST
Change (% chg)

$1.19 (+5.31%)
Prev Close
$22.40
Open
$22.71
Day's High
$24.00
Day's Low
$21.16
Volume
23,392
Avg. Vol
28,505
52-wk High
$25.57
52-wk Low
$7.74

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Jul 3.72 -0.466
FY 2018 Apr '18 4.84 -0.061
Jan '18 2.33 -0.485
Oct 1.13 -0.498
Jul 0.10 -0.507
FY 2017 Apr '17 0.11 -0.440
Jan '17 0.25 -0.998
FY 2016 Sep '16 0.01 -1.268
Jun '16 0.01 -3.907
Mar '16 0.01 -3.513
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Apr-18 2 3.65 5.00 2.30 --
Quarter Ending Jan-19 5 3.80 4.30 3.00 --
Year Ending Apr-18 2 7.25 8.60 5.90 --
Year Ending Apr-19 5 15.16 16.62 12.70 14.40
Year Ending Apr-20 5 23.94 43.80 10.00 28.80
Earnings (per share)
Quarter Ending Apr-18 2 -0.35 -0.26 -0.44 --
Quarter Ending Jan-19 5 -0.53 -0.40 -0.75 --
Year Ending Apr-18 2 -1.84 -1.74 -1.93 --
Year Ending Apr-19 5 -1.91 -1.28 -2.79 -1.40
Year Ending Apr-20 4 -1.97 -0.27 -3.59 -0.27
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 31.13 33.63
P/E High - Last 5 Yrs. -- 40.59 45.43
P/E Low - Last 5 Yrs. -- 23.99 24.43
Beta -- 0.91 0.90
Price to Sales (TTM) 151.44 4.00 5.77
Price to Book (MRQ) 2.63 5.02 5.12
Price to Tangible Book (MRQ) 2.63 5.76 6.54
Price to Cash Flow (TTM) -- 23.20 23.57
% Owned Institutions 80.82 0.95 1.83

Dividends

  Company industry sector
Dividend Yield -- 1.55 1.49
Dividend Yield - 5 Year Avg -- 1.56 1.50
Dividend 5 Year Growth Rate -- 4.21 5.08
Payout Ratio(TTM) -- 45.68 43.75

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 1,271.43 2.33 7.43
Sales (TTM) vs TTM 1 Yr. Ago 1,503.45 4.80 5.80
Sales - 5 Yr. Growth Rate -- 10.00 10.19
EPS (MRQ) vs Qtr. 1 Yr. Ago 87.02 17.26 21.03
EPS (TTM) vs TTM 1 Yr. Ago 75.80 -- --
EPS - 5 Yr. Growth Rate -- 9.88 10.79
Capital Spending - 5 Yr. Growth Rate -- 15.23 15.12

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.20 2.28
Current Ratio (MRQ) 7.87 3.02 3.11
LT Debt to Equity (MRQ) 0.80 8.89 11.47
Total Debt to Equity (MRQ) 1.55 12.69 15.63
Interest Coverage (TTM) -29.72 35.18 31.38

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 54.41 54.21
Gross Margin - 5 Yr. Avg. -- 51.86 51.98
EBITD Margin (TTM) -4,520.00 -- --
EBITD - 5 Yr. Avg -- 18.41 11.83
Operating Margin (TTM) -4,529.25 14.43 4.90
Operating Margin - 5 Yr. Avg. -- 14.55 7.44
Pre-Tax Margin (TTM) -4,120.21 14.96 5.91
Pre-Tax Margin - 5 Yr. Avg. -- 14.97 7.89
Net Profit Margin (TTM) -4,120.21 11.16 2.16
Net Profit Margin - 5 Yr. Avg. -- 11.23 4.12
Effective Tax Rate (TTM) -- 23.45 23.36
Effective Tax Rate - 5 Yr. Avg. -- 23.65 24.15

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 997,016,926 898,926,015
Net Income/Employee (TTM) -- 118,233,033 106,550,787
Receivable Turnover (TTM) -- 5.82 5.94
Inventory Turnover (TTM) -- 2.68 3.62
Asset Turnover (TTM) 0.01 0.99 0.97

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -55.70 11.98 11.50
Return on Assets - 5 Yr. Avg. -- 13.28 12.67
Return on Investment (TTM) -60.80 15.55 15.02
Return on Investment - 5 Yr. Avg. -- 17.28 16.45
Return on Equity (TTM) -61.05 16.92 16.60
Return on Equity - 5 Yr. Avg. -- 18.21 17.56
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -- -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Kalvista Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -12.01 -15.05 9 20
13 Week 1.40 -3.54 60 34
26 Week -3.33 -10.68 48 28
52 Week -4.10 -18.72 43 12
YTD 2.55 -9.94 46 25
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 78.49%
# of Holders: 61
Total Shares Held: 13,485,092
3 Mo. Net Change: 6,328,401
# New Positions: 30
# Closed Positions: 4
# Increased Positions: 42
# Reduced Positions: 14
# Net Buyers: 28
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.